Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. - Wikidata - wikimedia - TriplyDB

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

http://www.wikidata.org/entity/Q40973280

about

A novel toolbox for the in vitro assay of hepatitis D virus infection.Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors.Research progress of therapeutic vaccines for treating chronic hepatitis B.The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication.Antibody-mediated immunotherapy against chronic hepatitis B virus infection.A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.A potent human neutralizing antibody Fc-dependently reduces established HBV infections A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway.Antibody therapies for the prevention and treatment of viral infections.Immunotherapy for Chronic Hepatitis B Virus Infection.A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys.Humoral immunity, the underestimated player in hepatitis B.Animal models for the study of hepatitis B virus infection.Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress.The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice.A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection Circulating and intrahepatic antiviral B cells are defective in hepatitis B

P2860

Q37581726-9371DD9C-93F6-41C1-9DAA-CC9498E33024 Q39067120-2EEC1430-B064-4601-A115-0C5839EEC06A Q39101021-336F1AEA-CAB6-4578-B763-633B25ADB54E Q40070996-20B122E1-9107-4F92-8357-81DE30E7B8E9 Q40196246-A61EC5ED-C9E6-465E-AF91-DA7564806558 Q40893286-2F5DB7CF-6FF3-401B-A82A-36CDF1F748BD Q41671765-DF73D3AF-5F4F-4AD4-92EF-F7CFDF051928 Q47105994-BC4E94FB-C448-439F-91E3-1F30A65B87FB Q47143843-E8BC2717-F9DA-441E-B366-D8EE0F1D25D5 Q47556416-F61A4181-05D5-4894-8421-C5DB52C584B0 Q49772736-EA05333F-E4B4-4022-96B2-4062D7E8D0F2 Q49962982-DB73331F-5F72-4C60-87B0-E3DA1A986E33 Q52671153-B021CC0A-B8BC-4E00-909C-C68963AF0AD0 Q52689095-4BA72BF9-3843-45BE-8218-8B268B3A1CD0 Q54257015-2888761F-4E4C-42B4-B7BE-1CB14A818050 Q55325868-6BC7170A-1F21-48DF-9004-4188E159CA5E Q57201477-425E18E7-0924-44A9-8706-0B7C374CBADD Q58790980-749950B1-775C-4803-8137-B1C9280CDD33 Q58792007-EEEEF44A-21CA-4496-8891-2E09982D391D

P2860

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.

http://www.wikidata.org/entity/Q40973280

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Prolonged suppression of HBV i ...... n hepatitis B surface antigen.

@en

type

label

Prolonged suppression of HBV i ...... n hepatitis B surface antigen.

@en

prefLabel

Prolonged suppression of HBV i ...... n hepatitis B surface antigen.

@en

P1433

Q40973280-03CB4554-649D-41D1-AEBB-C46FD0C97E4D

P1476

Q40973280-533FC29F-4EC8-4DC2-8FD8-B6A80167862A

P2093

Q40973280-009535E7-4DC4-45FE-B5E7-A4FAB4A44DAF

Q40973280-08677C95-0EA2-4ED9-8286-2D96CEC78194

Q40973280-111246AF-24DE-4CA6-BD72-160A88114466

Q40973280-20A72BC7-EF23-4B12-B7C6-B2C97532521C

Q40973280-27E5D424-6AF0-4366-A520-1B13B9A3BDDF

Q40973280-2867C94D-BF21-4AFC-99F9-F0F317F29FB9

Q40973280-34EF360A-00C3-4E16-9DDD-B20FFC8C6959

Q40973280-412CA1F9-7D80-4F99-960A-1FB0502187E8

Q40973280-56762EF0-80FC-4C02-B723-986577862ECB

Q40973280-65F24BC2-D820-4D7C-8034-CE4573348D2B

P2860

Q40973280-127EF080-8B36-4C6E-85D5-0F2A15CE1989

Q40973280-1EBA07A5-D424-4FD9-970D-4E7C9B2B4194

Q40973280-1EC4E704-4B51-4823-B424-87A94B6E6376

Q40973280-20BB8680-061F-4370-8669-2299B5D3E83F

Q40973280-22A58E41-0520-4744-B1F8-BBEF34A652E5

Q40973280-286C1658-AC2F-4530-9316-1A122A013E0D

Q40973280-2C28D0C1-7373-4200-ADEC-5F3B4C2B734B

Q40973280-2D6FF6BD-CA3F-4981-B8EE-1CB6B0FDDB87

Q40973280-39F86FF6-ED65-4F00-900A-99EABE09835F

Q40973280-3D43F6B6-5BF3-4DA4-8001-A145803F089A

P304

Q40973280-B951914E-11DA-45E3-A662-E83E6CAF4AEB

P31

Q40973280-6B0B1308-1E24-456F-B795-0C6069F079B1

P356

Q40973280-CE9F4525-1949-46B6-8230-BDBD01140EB4

P407

Q40973280-E89EE5A2-EECE-4BC7-AD4A-F56510136CC8

P433

Q40973280-BB5AB2E2-D40E-4C3A-B420-4888F902A953

P478

Q40973280-6C20513B-BCA5-4DAA-BD20-40FDEA0B62A2

P50

Q40973280-2B66A87B-79A0-4583-8E6D-BF81D11D57CA

P577

Q40973280-482B9884-6138-4D42-A211-F66A49B8CE86

P5875

Q40973280-61A7D142-41BA-41D1-A444-969F7A3E3F00

P698

Q40973280-CB6F48BB-CBE4-4F2E-A580-338F5D8DB717

P356

GUTJNL-2014-308964

P1433

P1476

Prolonged suppression of HBV i ...... on hepatitis B surface antigen

@en

P2093

Chang-Ru Wu

http://www.w3.org/2001/XMLSchema#string

Cheng-Pu Sun

http://www.w3.org/2001/XMLSchema#string

James Wk Shih

http://www.w3.org/2001/XMLSchema#string

Jia-Li Cao

http://www.w3.org/2001/XMLSchema#string

Jing-Hua Zhao

http://www.w3.org/2001/XMLSchema#string

Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Jun-Fang Zhang

http://www.w3.org/2001/XMLSchema#string

Lun-Zhi Yuan

http://www.w3.org/2001/XMLSchema#string

Mi-Hua Tao

http://www.w3.org/2001/XMLSchema#string

Ning-Shao Xia

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors

Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc- Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

Effects of microparticle size and Fc density on macrophage phagocytosis

Fcgamma receptors as regulators of immune responses

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Pathogenesis of hepatitis B virus infection

Immune clearance of highly pathogenic SIV infection.

Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

P304

658-671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2014-308964

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282360879

http://www.w3.org/2001/XMLSchema#string

P698

26423112

http://www.w3.org/2001/XMLSchema#string